Trials / Completed
CompletedNCT00452621
Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years
A Phase IV, Uncontrolled, Open-Label, Multi-Center Study in Children and Adolescents: Evaluation of Long-Term Immunogenicity in Subjects Boosted With a New Pediatric TBE Vaccine (Free of Protein-Derived Stabilizer) in Study V48P4E1, Five Years After First Booster Immunization
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 235 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 6 Years – 16 Years
- Healthy volunteers
- Accepted
Summary
blood draw five years after booster-immunization with TBE vaccine to investigate immunogenicity in children
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | blood draw |
Timeline
- Start date
- 2007-02-01
- First posted
- 2007-03-27
- Last updated
- 2008-04-23
Locations
8 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00452621. Inclusion in this directory is not an endorsement.